Top Markets
Coin of the day
Liminal BioSciences Inc. Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNL
Clasificación en acciones #38948
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm,... Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.
Precio por acción
$8.50
Última sincronización: 2023-09-26
Capitalización bursátil
$719.10K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Liminal BioSciences Inc. (LMNL)

Categoría

Historial del precio de la acción de Liminal BioSciences Inc. (LMNL)
Precio más alto de cierre: $8.45 el 2023-09-01

Precio más bajo de cierre: $1.69K el 2009-12-01
Historial del precio de la acción de Liminal BioSciences Inc. desde 2009 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 112.62%
2022 -61.46%
2021 -76.57%
2020 -35.75%
2019 -97.45%
2018 -73.89%
2017 -28.49%
2016 -38.09%
2015 36.88%
2014 102.93%
2013 334.33%
2012 40.83%
2011 23.59%
2010 -34.41%
2009 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$507.69 30.08%
US
$848.55 30.06%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE